Chronic Obstructive
6
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Bgf
Research Leaders
15 sponsors active, led by AstraZeneca
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (6)
Exacerbations Among Patients Receiving Breztri (EROS Study)
Usage of Spacers and the Relationship With Symptoms Severity in COPD Elderly Patients
Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD
ICS/LABA Adherence and COPD Exacerbation
Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients
Research Network
Common Treatments
- Bgf1
- Noninterventional Study1
- Nonlinear Periodized Resistance Training1
- Resistance Training1
- Zopiclone1
Active Sponsors
- AstraZeneca2
- Merem Pulmonary Rehabilitation Centre1
- ResMed1
- LHL Helse1
- University Hospital, Akershus1
Top Investigators
Umeå University
AstraZeneca
Da-Yeh University
AstraZeneca
Brigham and Women's Hospital
Related Conditions
- Pulmonary Disease6
- Arrhythmias Cardiac1
- Asthma1
- Hypercapnia1
- Hypoxemia1